Hui David, Shamieh Omar, Paiva Carlos Eduardo, Khamash Odai, Perez-Cruz Pedro Emilio, Kwon Jung Hye, Muckaden Mary Ann, Park Minjeong, Arthur Joseph, Bruera Eduardo
Department of Palliative Care and Rehabilitation Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Department of Palliative Care, King Hussein Cancer Center, Amman, Jordan.
J Pain Symptom Manage. 2016 Feb;51(2):262-9. doi: 10.1016/j.jpainsymman.2015.10.004. Epub 2015 Oct 19.
The Edmonton Symptom Assessment System (ESAS) is one of the most commonly used symptom batteries in clinical practice and research.
We used the anchor-based approach to identify the minimal clinically important difference (MCID) for improvement and deterioration for ESAS physical, emotional, and total symptom distress scores.
In this multicenter prospective study, we asked patients with advanced cancer to complete their ESAS at the first clinic visit and at a second visit three weeks later. The anchor for MCID determination was Patient's Global Impression regarding their physical, emotional, and overall symptom burden ("better," "about the same," or "worse"). We identified the optimal sensitivity/specificity cutoffs for both improvement and deterioration for the three ESAS scores and also determined the within-patient changes.
A total of 796 patients were enrolled from six centers. The ESAS scores had moderate responsiveness, with area under the receiver operating characteristic curve between 0.69 and 0.76. Using the sensitivity-specificity approach, the optimal cutoffs for ESAS physical, emotional, and total symptom distress scores were ≥3/60, ≥2/20, and ≥3/90 for improvement, and ≤-4/60, ≤-1/20, and ≤-4/90 for deterioration, respectively. These cutoffs had moderate sensitivities (59%-68%) and specificities (62%-80%). The within-patient change approach revealed the MCID cutoffs for improvement/deterioration to be 3/-4.3 for the physical score, 2.4/-1.8 for the emotional score, and 5.7/-2.9 for the total symptom distress score.
We identified the MCIDs for physical, emotional, and total symptom distress scores, which have implications for interpretation of symptom response in clinical trials.
埃德蒙顿症状评估系统(ESAS)是临床实践和研究中最常用的症状评估量表之一。
我们采用基于锚定的方法来确定ESAS身体、情绪及总症状困扰评分改善和恶化的最小临床重要差异(MCID)。
在这项多中心前瞻性研究中,我们要求晚期癌症患者在首次门诊就诊时及三周后的第二次就诊时完成ESAS评估。用于确定MCID的锚定指标是患者对其身体、情绪及总体症状负担的整体印象(“好转”“大致相同”或“恶化”)。我们确定了三个ESAS评分改善和恶化的最佳灵敏度/特异度临界值,并确定了患者内变化情况。
共从六个中心招募了796名患者。ESAS评分具有中等反应性,受试者工作特征曲线下面积在0.69至0.76之间。采用灵敏度-特异度方法,ESAS身体、情绪及总症状困扰评分改善的最佳临界值分别为≥3/60、≥2/20和≥3/90,恶化的最佳临界值分别为≤ -4/60、≤ -1/20和≤ -4/90。这些临界值具有中等灵敏度(59%-68%)和特异度(62%-80%)。患者内变化方法显示,身体评分改善/恶化的MCID临界值为3/-4.3,情绪评分为2.4/-1.8,总症状困扰评分为5.7/-2.9。
我们确定了身体、情绪及总症状困扰评分的MCID,这对解释临床试验中的症状反应具有重要意义。